HEALTH
Australian Cancer Patients: High Costs and Hospital Stays from Therapy Complications
Victoria, AustraliaSun Feb 09 2025
Over a span of 14 years, Australian cancer patients faced challenges such as post-therapy complications after treatment, particularly systemic therapy and radiotherapy, leading to unplanned hospital stays.
With a focus on 8, 633 cancer patients and over 1 million emergency hospital admissions, the study showed that complications increased significantly each year.
In fact, the yearly rise in complications due to therapy leading to unplanned visits to the hospital was 7. 25%, while the overall hospital admissions grew by 5. 66%.
The study shows that most patients, around 71%, experienced multiple complications. The most common issues included anemia, sepsis, nausea and vomiting, and neutropenia, resulting in extra days spent in the hospital and increased medical costs.
Patients who underwent both systemic therapy and radiotherapy had a higher chance of complications than those who received only systemic therapy.
Post-therapy complications added 1. 72 longer stays in the hospital, resulting in a total of 360 days per patient,whereas patients without complications stayed 6. 48 days. Patients who had complications faced higher medical hospitalization costs, with an additional $8, 817 per admission.
The overall costs for unplanned hospitalizations due to post-therapy complications were significantly higher, exceeding $1. 82 million for each patient, compared to $33, 599 for patients who did not experience complications. This variation in cost and hospital stay duration was influenced by the type of therapy and the specific cancer diagnosis.
The study emphasized the need for personalized treatment plans to address these issues better and optimize the use of resources in cancer treatment.
Given these insights, it is clear that the healthcare system needs to focus on reducing the burden of post-therapy complications.
It is crucial for healthcare professionals to consider the long-term impact of treatments on patients and work towards more effective and less harmful treatment options.
continue reading...
questions
Why do post-therapy complications seem to prefer male cancer patients, given that 52% of them are male?
Could there be pharmaceutical companies that are profiting from the increased hospital admissions due to post-therapy complications?
How can cancer patients convince the immune system to stop being such a picky eater?
inspired by
actions
flag content